Ann-Christine M. Sundell

Ann-Christine M.
Sundell currently works at Medix Biochemica Oy Ab, as Chairman from 2015, Serres Oy, as Chairman, Medix Biochemica Group Oy, as Chairman from 2011, Actim Oy, as Chairman, Acmer AB, as Chairman, Revenio Group Oyj, as Independent Director from 2016, Förlags AB Sydvästkusten, as Director, Ledil Oy, as Director from 2015, Ledil Group Oy, as Director, Biocartis Group NV, as Independent Director from 2018, Biocartis NV, as Independent Director from 2018, Blueprint Genetics Oy, as Director from 2017, Aconsult Sia, as Director, Paree Group Oy, as Director from 2012, Bcbm Holding Oy, as Director, Minervastiftelsen sr, as Director, Archipelagia Golf Club Oy, as Director, Au Media AB, as Director, Ekofish AB, as Director, SyntheticMR AB, as Director from 2021, The Association for Diagnostics & Laboratory Medicine, as Member, American Society of Human Genetics, as Member, International Federation of Clinical Chemistry & Lab Medicine, as Member, and International Society for Neurochemistry, Inc., as Member.
Ms. Sundell also formerly worked at Raisio Oyj, as Vice Chairman from 2019 to 2025, Immunovia AB, as Director, Oy Medix Ab, as Director, Zymonostics ApS, as Director, Minerva Foundation Institute For Medical Research, as Director, Vanadis AB, as Director, Revvity, Inc., as President & Manager-Segment, Sales & Marketing from 1999 to 2010, and Revvity Oy, as President-Strategic Business Enterprise from 2000 to 2010.
Ms. Sundell received her graduate degree from Åbo Akademi University.